Anthony Epps

Anthony regularly assists clients with complex securities transactions including a variety of public and private offerings, M&A transactions including reverse mergers, corporate governance, FINRA compliance, Regulation M compliance, and ongoing U.S. Securities Act and Exchange Act Reporting.

Selected Merger and Acquisition Transactions

• Represented San Cristobal Mining in its acquisition of Minera San Cristobal SA and all of its assets from Sumitomo Corporation
• Represented Aytu BioScience in connection with its merger with Innovus Pharmaceuticals
• Represented Purple Innovation, LLC (now Purple Innovation, Inc.) in its merger with Global Partners Acquisition Corp., a SPAC, and related PIPE offering of Class A Common Stock and listing on the NASDAQ capital market
• Represented Amesite, Inc. in its reverse merger transaction with Lola One Acquisition Corp.
• Represented Energy Fuels Inc.  in its acquisition by Uranerz Energy Corporation
• Represented Rezolute, Inc. in its reverse merger transaction with Fits My Style Inc.
• Represented Franklin Covey Co. in multiple acquisitions

Selected IPOs, Follow-Ons and Secondary Offerings

• Represented Rezolute, Inc. in its $40 million private placement
• Represented Purple Innovation Inc. in its 2020 registered secondary offering of Class A Common Stock
• Represented Lipocine Inc. in its 2020 Registered Direct Offering to institutional investors
• Issuer’s counsel for Avinger, Inc. in multiple public offerings of common stock
• Represented Purple Innovation, Inc. in its 2019 registered secondary offering of Class A Common Stock
• Represented Lipocine Inc. in its 2019 confidentially marketed public offering of common stock and warrants
• Issuer’s counsel for Aytu BioScience, Inc. in its public offering of common stock, preferred stock, and warrants
• Issuer’s counsel for Aytu BioScience. in its registered direct offerings
• Issuer’s counsel for Aytu BioScience, in its at-the-market offering
• Issuer’s counsel for Purple Innovation, Inc. in its PIPE offering of Class A Common Stock
• Issuer’s counsel for BSD Medical Corporation in a shelf takedown and Registered Direct Offering to institutional investors 
• Issuer’s counsel for BSD Medical Corporation in its shelf takedown and at-the-market (ATM) offering
• Issuer’s counsel for Lipocine Inc. in its post-effective amendment S-1 in connection with a PIPE offering to institutional investors
• Issuer’s counsel Nu Skin Enterprises, Inc. in a registered secondary offering of Class A Common Stock